| Mobile Web

Canary Capital lists Injective staking spot ETF INJC on Nasdaq

Asset manager Canary Capital has listed a staking spot exchange-traded fund holding Injective token INJ on Nasdaq. The Canary Staked INJ ETF, ticker INJC, tracks INJ’s spot price while staking at least 90 percent of its holdings to earn rewards that are reflected in net asset value after fees and re-staked. The prospectus estimates annualised staking rewards of about 6.8 percent and total annual fees of 1.10 percent. Injective Foundation plans to invest up to $15 million as a seed investor.